ARCHIVES

Phase II Study Tests Chemo Plus Mylotarg For AML

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Prevention Fellowship Program Offers Enhancement

March 8, 1991

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

Tamoxifen Listed By IARC Report As Carcinogen CTRF Seeks Applicants

March 1, 1996

Jury Awards $14 Million To Medenica Patient

February 24, 1995

NCI-Approved Clinical Trials

July 29, 2005

In Brief: Broder Wins ARC’s Griffuel Prize; Lawyers Trained To Help Low-Income Breast Ca, Patients

October 16, 1992